Life Science

The inactive isomer of omeprazole, a gastric proton-pump inhibitor its hydroxylation is mediated stereoselectively by CYP2C19.

The inactive isomer of omeprazole, a gastric proton-pump inhibitor its hydroxylation is mediated stereoselectively by CYP2C19.

The inactive isomer of omeprazole, a gastric proton-pump inhibitor its hydroxylation is mediated stereoselectively by CYP2C19.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

A cyanogenic glucoside that is the precursor to amygdalin and can be degraded to hydrogen cyanide, glucose, and benzaldehyde possesses inhibitory effects on plant growth and inhibits DNA polymerase &beta (IC₅₀ = 98 &microM).